Proposed Revision in the International Committee of Medical Journal Editors (ICMJE) Authorship Criteria
Subhash Varma
Citation Information :
Varma S. Proposed Revision in the International Committee of Medical Journal Editors (ICMJE) Authorship Criteria. J Postgrad Med Edu Res 2016; 50 (2):108-109.
Available from: http://www.icmje.org/news-and-editorials/new_rec_aug2013.html. [Accessed 2015 Sep 09].
Telomerase inhibitor imetelstat in patients with essential thrombocythemia. N Engl J Med 2015;373(10): 920-928.
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS). Lancet Infect Dis 2015;15(4):397-404.
ODYSSEY LONG TERM Investigators. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med 2015;372(16):1489-1499.
Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group. Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial. JAMA 2015;314(9): 884-894.
How industry uses the ICMJE guidelines to manipulate authorship--and how they should be revised. PLoS Med 2011 Aug;8(8):e1001072.
